jobs.pl/Oferty pracy/Badania i rozwój/AI Biologist - Genetic Medicines
Źródło: CrawlJobs

AI Biologist - Genetic Medicines

Employment contract Full-time On-site work

Publication date: 05/11/2026

Latch builds rigorous scientific benchmarks for AI agents across biology. The company works with frontier labs and pharma to measure whether agents can handle real biological workflows. The AI Biologist - Genetic Medicines will contribute to the technical approach for evaluating agent performance at reasoning across the genetic medicines pipeline, including gene therapy, gene editing, and RNA therapeutics, from target validation and drug discovery to clinical development. The role works as part of a team of software engineers and scientists building datasets and AI agent tasks. Interview process: take-home project (HackerRank), technical interview with a Member of Technical Staff, culture interview with the C-suite, offer, and background check once accepted.

Responsibilities

Contribute to the technical approach for evaluating agent performance at reasoning across the genetic medicines pipeline; Work as part of a team of software engineers and scientists building datasets and AI agent tasks across the end-to-end genetic medicines pipeline; Design realistic program case studies spanning target validation, drug design and screening, chemistry optimization, candidate nomination, and IND-enabling studies across genetic medicine modalities; Evaluate PK/PD, immunogenicity, and GLP toxicology findings across modalities and development stages; Reconstruct program go/no-go decisions from multi-source data; Review and stress-test agent outputs for scientific soundness, catching reasoning that is textbook-correct but not defensible in a program review; Calibrate AI agent confidence on preclinical data with incomplete or conflicting signals, rather than forcing a binary call

Requirements

Advanced degree (MS/PhD/PharmD) in molecular biology, genetics, gene therapy, or a related biomedical field, or equivalent industry experience; 3+ years of hands-on experience in gene therapy, gene editing, or RNA therapeutics (ASO/siRNA/mRNA) discovery or development; Direct experience with drug design, drug screening, delivery optimization, or IND-enabling study design in at least one genetic medicine modality; Experience interpreting on-/off-target editing data, biodistribution, immunogenicity, and GLP toxicology to inform dose selection and risk assessment; Experience evaluating potency, specificity, and developability trade-offs across vector, construct, or oligonucleotide candidates; Strong scientific writing skills, able to produce clear, evidence-supported rationale for a drug development decision; Proficiency in AI agent use, with the judgment to identify where model reasoning is technically correct but pharmacologically or practically unsound; Comfort operating in uncertainty, and proactively flagging gaps in data or instructions; Works with high agency and initiative

Nice to have

Familiarity with IND-enabling regulatory requirements and the nonclinical data package expected by FDA/EMA

Benefits

Health, dental, vision: 100% covered for you, 50% for dependents (US full-time W-2); 401(k) (no match); PTO: 12 days to start, more as you're promoted; Guaranteed base salary set by state, paid every paycheck; Monthly advance of 60% of OTE that's never clawed back (outside the US, contractor); Company outings most months, team off-sites, and community activities; Catered lunch and dinner and unlimited snacks at Mission Bay office; Work authorization sponsorship: H-1B (new and transfers), O-1, and TN, and support for STEM OPT; Individual contributor and management growth tracks based on output
Apply with employer

Podobne oferty

Wszystkie →

Dostosuj zgody

Każdy cel jest opcjonalny i domyślnie wyłączony. Zgodę możesz wycofać w dowolnym momencie.

Pokazujemy oferty najbliżej Ciebie